Tuesday, 9th September
CD1-MR1 Workshop 2025
Days
Tuesday, 9th September
Wednesday, 10th September
Thursday, 11th September
Friday, 12th September
Search
Speakers
Registration Opens
8:00AM - 4:00PM
Tuesday, 9th September
Foyer Area
Breakfast & Networking
8:00AM - 9:00AM
Tuesday, 9th September
Foyer Area
Welcome Remarks
9:00AM - 9:20AM
Tuesday, 9th September
Auditorium
Chairs: David Lewinsohn & Annemieke de Jong
Additional Chairs: Lydia Lynch, Branch Moody, Dan Pellicci and Corinna Kulicke
Opening Keynote Introduction
9:20AM - 9:25AM
Tuesday, 9th September
Auditorium
Chair: Sidonia Eckle
Opening Keynote Address
9:25AM - 10:10AM
Tuesday, 9th September
Auditorium
Chair: Sidonia Eckle
The emerging role of MAIT cells and broader MR1-reactive T cell Immunity
-
James McCluskey
CD1 and MR1 Antigen Display 1
10:10AM - 10:35AM
Tuesday, 9th September
Auditorium
Chairs: Annemieke de Jong & Minori Asa
Exposure to Mycobacteria Shapes the Phenotype and TCR Repertoire of MR1Ts
-
David Lewinsohn
Morning Coffee Break & Networking
10:35AM - 11:05AM
Tuesday, 9th September
Foyer Area
CD1 and MR1 Antigen Display 1
11:05AM - 12:30PM
Tuesday, 9th September
Auditorium
Chairs: Annemieke de Jong & Minori Asa
Using Cellular CD1 Ligands to Design Lipid Inhibitors of Skin Inflammation
-
Branch Moody
Identification of conserved CD1b motif (RExxD) that interacts with TRBV4-1
-
Minori Asa
Acetoacetate suppresses colon cancer via an MR1-MAIT axis
-
Slater L Clay
Agilent and Panome Bio Talk
-
Speaker To Be Announced
Agilent Technologies Lunch & Networking
12:30PM - 1:30PM
Tuesday, 9th September
Foyer Area
Sponsored by:
Agilent Technologies
CD1 MR1 Society Announcement
1:30PM - 1:40PM
Tuesday, 9th September
Auditorium
Chair: Agnes Lehuen
CD1 and MR1 Antigen Display 2
1:40PM - 2:55PM
Tuesday, 9th September
Auditorium
Chairs: Agnes Lehuen & Andy Hogan
CD1a-reactive T cells and the skin: therapeutic potential of inhibition
-
Graham Ogg
Calcium signaling in MR1 presentation of
Mycobacterium tuberculosis
infection
-
Elly Karamooz
MAIT cell responses to intracellular and extracellular pathogens are mediated by distinct antigen presenting cells
-
Michael G. Constantinides
Afternoon Coffee Break & Networking
2:55PM - 3:30PM
Tuesday, 9th September
Foyer Area
CD1 and MR1 Antigen Display 2
3:30PM - 4:35PM
Tuesday, 9th September
Auditorium
Chairs: Agnes Lehuen & Andy Hogan
A little bit on the side
-
Jamie Rossjohn
Optimisation of NKT cell-mediated adjuvant activity for mRNA vaccines
-
Gavin Painter
The antigen presenting molecule MR1 binds riboflavin catabolites
-
Wael Awad
Lightning Talks 1
4:35PM - 5:00PM
Tuesday, 9th September
Auditorium
Chair: Hui-Fern Koay
Patient-derived pancreatic tumor bacteria exhibit oncogenic properties and are recognized by MAIT cells in tumor spheroids
-
Michał J Sobkowiak
Advances in the characterisation of antigen presentation by group 1 CD1 antigen-presenting molecules
-
Adam Shahine
Understanding the molecular basis of autoreactive T cell recognition of CD1a presenting self-lipid antigen
-
Jia Jia Lim
Investigating the role of CD1a and CD1d in Nickel Allergic Contact Dermatitis
-
Aoife Clancy
Generative Diffusion-Based
De Novo
Protein Design of Lipid/CD1-Restricted TCR Mimics
-
Andrew McShan
Small molecules from conserved metabolic pathways form alternate 5-A-RU-based MR1 ligands that are recognised by MAIT cells
-
Michael NT Souter
Antibody-dependent cellular cytotoxicity of iPS cell-derived natural killer T cells by anti-GD2 mAb for neuroblastoma
-
Katsuhiro Nishimura
Characterization of bile acids as novel MR1 ligands
-
Alejandro Briones-Contreras
Poster Session 1
5:00PM - 6:30PM
Tuesday, 9th September
Foyer Area
Molecular insights into the capability of the MR1 molecule to display host-derived metabolites for T cell surveillance
-
Wael Awad
Proximal tubule CD1d and natural killer T-cells in acute cardiorenal syndrome
-
Kevin G Burfeind
DEVELOPMENT OF REJECTION-RESISTANT ALLOGENEIC CAR-NKT CELL THERAPY FOR CD19-POSITIVE B CELL MALIGNANCIES
-
Kshiti Dholakia
High throughput discovery approaches identify human self-metabolites of several chemical classes as antigens for MAIT cells
-
Iria Gomez-Tourino
Activated MAIT cells drive fibrosis in primary sclerosing cholangitis in a SPARC dependent manner
-
Florencia Gutierrez
Analysis of collaborative cross mouse strains to identify genes differentially involved in MAIT
versus
NKT cell thymic development
-
Emi Ito
Synaptotagmin 1 and Synaptotagmin 7 promote MR1-mediated presentation of
Mycobacterium tuberculosis
antigens
-
Se-Jin Kim
Mutations outside the MR1 antigen binding groove differentially inhibit presentation of exogenous antigens
-
Corinna A Kulicke
Development of a sensitive, scalable assay for MR1-bound 5-OP-RU
-
Martin Lett
Investigating the molecular basis by which antigens are loaded onto different MR1 variants
-
Victoria Letoga
Discovering isoform-specific lipidomic signatures associated with human CD1 proteins
-
Shuqi Li
Understanding the Molecular Mechanism of Recognition of
Bacteroides fragilis
produced glycosphingolipids by Natural Killer T (NKT) cell Receptors
-
Vasudha Maddali
Metabolomic analysis of mammalian-derived MR1-ligands
-
Edward J Mathias
Probing CD1d mediated lipid specific iNKT interactions in solution
-
Uri Z Miles
Identification of self-metabolites as MR1 ligands and autoantigens in Type 1 diabetes
-
Lucía Mosquera-Ferreiro
Allelic variation of MR1 shapes its antigen repertoire and presentation capacity
-
Adam G Nelson
TCR-dependent MAIT cell activation controls visual function
-
Kensuke Shibata
NAADP-mediated endosomal calcium signaling enables MR1 presentation of
Mycobacterium tuberculosis
-
Allison Tammen
Multimodal profiling of phosphomycoketide-reactive γδ T cells in BCG-vaccinated South African infants
-
Tori Tappen
Deciphering the molecular basis of headless lipid recognition by NKT cells
-
Praveena Thirunavukkarasu
Crohn’s disease-Associated Invariant T (CAIT) cells from Crohn’s disease patients are activated by hydrophobic antigens in human ileum
-
Ildiko Van Rhijn
Allogeneic NKT Cells Expressing a CD19-specific CAR in Patients with Relapsed or Refractory B cell Malignancies: an Interim Analysis
-
Leonid Metelitsa
Networking Function - Deschutes Brewery - ticketed event
7:30PM - 10:00PM
Tuesday, 9th September
Wednesday →